Side effects across medicines
Medicines whose labels list weight loss
365 medicines have an FDA label that names weight loss in its boxed warning, warnings, adverse reactions, trial table, patient leaflet or Drug Facts “stop use” warning (of the labels PlainMeds reads: each medicine's quoted label and up to eight more, by route and wording). Among them, the most FAERS reports of weight loss name adalimumab (12,898), ergocalciferol (12,632) and methotrexate (11,257), through July 30, 2026. A label lists what its studies and reports found, and a report does not show that a medicine caused the event.
Check it at the source: the FDA FAERS public dashboard; FDA labels on DailyMed.
Which medicines' labels list weight loss?
Ordered by where the label names it, the boxed warning first, then by FAERS reports. The first 152 of the 365 are below; every other one is on its medicine record. A medicine whose own indications name it, because it treats it, is not counted.
| Medicine | Where a label names it | FAERS reports of weight loss |
|---|---|---|
| Octreotide | warnings and precautions (oral label) | 2,280 |
| Amphetamine and dextroamphetamine | precautions | 1,166 |
| Rivastigmine | warnings and precautions (transdermal label) | 593 |
| Gemfibrozil | precautions | 428 |
| Metolazone | precautions | 359 |
| Rifampin | precautions | 262 |
| Melphalan | precautions | 178 |
| Dextroamphetamine | precautions | 161 |
| Amphetamine | precautions | none in the top 1,000 |
| Doxercalciferol | warnings and precautions (oral label) | none in the top 1,000 |
| Entacapone | precautions | none in the top 1,000 |
| Ethacrynic acid | warnings (intravenous label) | none in the top 1,000 |
| Paricalcitol | warnings and precautions (intravenous label) | none in the top 1,000 |
| Pasireotide | warnings and precautions | none in the top 1,000 |
| Tiagabine | precautions | none in the top 1,000 |
| Ergocalciferol | adverse reactions | 12,632 |
| Levothyroxine | adverse reactions | 9,650 |
| Infliximab | adverse reactions | 7,434 |
| Amlodipine | adverse reactions | 6,154 |
| Alprazolam | adverse reactions | 5,450 |
| Apremilast | adverse reactions | 5,046 |
| Lenalidomide | adverse reactions | 4,996 |
| Clonazepam | adverse reactions | 4,774 |
| Carvedilol | adverse reactions | 3,501 |
| Hydroxychloroquine | adverse reactions | 3,355 |
| Escitalopram | adverse reactions | 3,343 |
| Citalopram | adverse reactions | 3,214 |
| Zolpidem | adverse reactions | 3,077 |
| Nintedanib | adverse reactions | 3,040 |
| Cabozantinib | adverse reactions | 3,038 |
| Topiramate | adverse reactions | 2,983 |
| Venlafaxine | adverse reactions | 2,951 |
| Sertraline | adverse reactions | 2,921 |
| Sodium oxybate | adverse reactions | 2,783 |
| Mycophenolate mofetil | adverse reactions | 2,760 |
| Fluoxetine | adverse reactions | 2,743 |
| Peginterferon alfa 2a | adverse reactions | 2,659 |
| Ribavirin | adverse reactions | 2,588 |
| Bupropion | adverse reactions | 2,561 |
| Mirtazapine | adverse reactions | 2,244 |
| Pirfenidone | adverse reactions | 2,231 |
| Levetiracetam | adverse reactions | 2,073 |
| Capecitabine | adverse reactions | 2,043 |
| Lamotrigine | adverse reactions | 2,013 |
| Palbociclib | adverse reactions | 1,982 |
| Bevacizumab | adverse reactions | 1,967 |
| Everolimus | adverse reactions | 1,920 |
| Nivolumab | adverse reactions | 1,847 |
| Pembrolizumab | adverse reactions | 1,817 |
| Baclofen | adverse reactions (intrathecal label) | 1,809 |
| Fentanyl | adverse reactions (transdermal label) | 1,801 |
| Enzalutamide | adverse reactions | 1,784 |
| Letrozole | adverse reactions | 1,683 |
| Sunitinib | adverse reactions | 1,588 |
| Duloxetine | adverse reactions | 1,497 |
| Cyclosporine | adverse reactions | 1,490 |
| Natalizumab | adverse reactions | 1,438 |
| Lenvatinib | adverse reactions | 1,431 |
| Risperidone | adverse reactions | 1,418 |
| Carbidopa and levodopa | adverse reactions | 1,413 |
| Insulin human | adverse reactions (respiratory (inhalation) label) | 1,304 |
| Ibrutinib | adverse reactions | 1,289 |
| Trastuzumab | adverse reactions | 1,140 |
| Divalproex | adverse reactions | 1,082 |
| Fulvestrant | adverse reactions | 1,057 |
| Clozapine | adverse reactions | 989 |
| Oxaliplatin | adverse reactions | 976 |
| Nifedipine | adverse reactions | 963 |
| Tramadol | adverse reactions | 941 |
| Anastrozole | adverse reactions | 925 |
| Sorafenib | adverse reactions | 917 |
| Pazopanib | adverse reactions | 882 |
| Cannabidiol | adverse reactions | 864 |
| Zoledronic acid | adverse reactions | 852 |
| Lomitapide | adverse reactions | 842 |
| Paroxetine | adverse reactions | 837 |
| Axitinib | adverse reactions | 802 |
| Donepezil | adverse reactions | 797 |
| Atomoxetine | adverse reactions | 746 |
| Vismodegib | adverse reactions | 738 |
| Cetuximab | adverse reactions | 685 |
| Ipilimumab | adverse reactions | 669 |
| Pomalidomide | adverse reactions | 663 |
| Selinexor | adverse reactions | 648 |
| Regorafenib | adverse reactions | 636 |
| Nilotinib | adverse reactions | 631 |
| Trofinetide | adverse reactions | 579 |
| Aprepitant | adverse reactions | 574 |
| Oxcarbazepine | adverse reactions | 570 |
| Buprenorphine | adverse reactions (transdermal label) | 556 |
| Etonogestrel | adverse reactions | 544 |
| Epoetin | adverse reactions | 542 |
| Calcitriol | adverse reactions | 516 |
| Cholestyramine | adverse reactions | 516 |
| Glatiramer | adverse reactions | 481 |
| Lithium | adverse reactions | 469 |
| Roflumilast | adverse reactions | 447 |
| Eszopiclone | adverse reactions | 433 |
| Amikacin | adverse reactions (respiratory (inhalation) label) | 431 |
| Fenfluramine | adverse reactions | 431 |
| Ropinirole | adverse reactions | 426 |
| Indapamide | adverse reactions | 413 |
| Pramipexole | adverse reactions | 409 |
| Progesterone | adverse reactions | 404 |
| Calcium oxybate, magnesium oxybate, potassium oxybate and sodium oxybate | adverse reactions | 403 |
| Naltrexone | adverse reactions | 403 |
| Lanreotide | adverse reactions | 398 |
| Bicalutamide | adverse reactions | 381 |
| Medroxyprogesterone | adverse reactions (subcutaneous label) | 377 |
| Trazodone | adverse reactions | 371 |
| Valproic acid | adverse reactions | 362 |
| Isotretinoin | adverse reactions | 361 |
| Emtricitabine and tenofovir disoproxil | adverse reactions | 351 |
| Thalidomide | adverse reactions | 337 |
| Brentuximab vedotin | adverse reactions | 318 |
| Buspirone | adverse reactions | 310 |
| Rasagiline | adverse reactions | 308 |
| Tenofovir disoproxil | adverse reactions | 304 |
| Liothyronine | adverse reactions | 298 |
| Rucaparib camsylate | adverse reactions | 296 |
| Haloperidol | adverse reactions (intramuscular label) | 295 |
| Interferon beta 1b | adverse reactions | 290 |
| Lopinavir and ritonavir | adverse reactions | 281 |
| Erlotinib | adverse reactions | 278 |
| Valganciclovir | adverse reactions | 276 |
| Ertapenem | adverse reactions | 273 |
| Ketoprofen | adverse reactions | 265 |
| Hydrochlorothiazide and lisinopril | adverse reactions | 259 |
| Trastuzumab deruxtecan | adverse reactions | 257 |
| Captopril | adverse reactions | 252 |
| Apalutamide | adverse reactions | 245 |
| Zonisamide | adverse reactions | 244 |
| Vincristine | adverse reactions | 243 |
| Panitumumab | adverse reactions | 240 |
| Febuxostat | adverse reactions | 225 |
| Terbinafine | adverse reactions | 222 |
| Azacitidine | adverse reactions | 219 |
| Irinotecan | adverse reactions | 208 |
| Afatinib | adverse reactions | 207 |
| Enfortumab vedotin | adverse reactions | 201 |
| Bendamustine | adverse reactions | 199 |
| Timolol | adverse reactions (oral label) | 196 |
| Crizotinib | adverse reactions | 195 |
| Zidovudine | adverse reactions | 183 |
| Clofazimine | adverse reactions | 179 |
| Talquetamab | adverse reactions | 174 |
| Tucatinib | adverse reactions | 166 |
| Ripretinib | adverse reactions | 165 |
| Abemaciclib | adverse reactions | none in the top 1,000 |
| Abiraterone and niraparib | adverse reactions | none in the top 1,000 |
| Adalimumab | patient leaflet | 12,898 |
| Methotrexate | patient leaflet | 11,257 |
Source: FDA drug labels via openFDA, read October 8, 2026; FAERS via openFDA, reports through July 30, 2026
Which of them have the most weight loss reports in FAERS?
Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; MedDRA preferred term “Weight Decreased”
What next?
- Side effects across medicines
- every reaction on PlainMeds
- Report a side effect to the FDA
- MedWatch